Japan· JP-2646727M1022
アルクロメタゾンプロピオン酸エステル
A alclometasone product containing アルクロメタゾンプロピオン酸エステル, registered in Japan by シオノギファーマ, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Alclometasone is registered in 7 of 19 countries.
Countries holding a registration under ATC D07AB10 (alclometasone), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 4 of them publish a price we can compare per daily dose
Alclometasone · ATC D07AB10
7 / 19 countries
- Czechiaprice
- Finlandprice
- Ireland
- Japan
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アルクロメタゾンプロピオン酸エステル
- Manufacturer
- シオノギファーマ
- Country
- Japan (JP)
- ATC code
- D07AB10
- ATC class
- Alclometasone
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for alclometasone.
Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Alclometasone · interactions on record
55 records
Same medicine, other countries
Alclometasone in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAlclometasone 0.05% creamAlliance Healthcare (Distribution) Ltd
- PolandAflodermInPharm Sp. z o.o.
- United StatesAlclometasone dipropionateSun Pharmaceutical Industries, Inc.
- CzechiaAFLODERMBelupo, s.r.o., Bratislava
- IrelandModrasone Cream 0.05% w/wAspire Pharma (Malta) Limited
- FinlandLegedermSchering-Plough Europe
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Czechia · Afloderm
- United Kingdom (Northern Ireland) · Alclometasone Dipropionate Aspire, Modrasone
- Croatia · Afloderm
- Ireland · Modrasone
- Poland · Afloderm
- Slovenia · Afloderm
- Slovakia · Afloderm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d02588d3-0274-40d3-a03e-8d66c7a915e3 GET /v1/drugs/d02588d3-0274-40d3-a03e-8d66c7a915e3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．１％１ｇ",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2646727M1022",
"category": "外用薬",
"price_yen": 18,
"generic_name": "アルクロメタゾンプロピオン酸エステル",
"product_name_jp": null,
"therapeutic_class": "2646",
"transitional_expiry": null
}See everything about alclometasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.